QRG Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
22,581
+2,519
| +13% | +$317K | 0.02% | 412 |
|
|
2025
Q1 | $2.22M | Buy |
20,062
+1,330
| +7% | +$147K | 0.02% | 437 |
|
|
2024
Q4 | $2.56M | Buy |
18,732
+453
| +2% | +$61.8K | 0.03% | 412 |
|
|
2024
Q3 | $2.11M | Buy |
18,279
+569
| +3% | +$65.6K | 0.02% | 433 |
|
|
2024
Q2 | $2.44M | Buy |
17,710
+1,832
| +12% | +$252K | 0.03% | 380 |
|
|
2024
Q1 | $2.19M | Buy |
15,878
+1,352
| +9% | +$186K | 0.03% | 399 |
|
|
2023
Q4 | $1.91M | Buy |
14,526
+1,685
| +13% | +$222K | 0.03% | 407 |
|
|
2023
Q3 | $1.44M | Buy |
+12,841
| New | +$1.44M | 0.03% | 428 |
|